Product (drug) shortages have had a significant impact on the healthcare system, particularly on patients and clinicians. This has been especially true with patients requiring parenteral nutrition (PN). The American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) has dealt with PN product shortages in the past on behalf of its members and their patients. However, the shortage severity and duration have made dealing with the PN product shortages in 2010–2012 extremely challenging.
KaakehRSweetBVReillyC. Impact of drug shortages on U.S. health systems. Am J Health Syst Pharm. 2011;68:1811-1819.
4.
Office of the Press Secretary. We can’t wait: Obama administration takes action to reduce prescription drug shortages, fight price gouging. http://www .whitehouse.gov/the-press-office/2011/10/31/we-can-t-wait-obama- administration-takes-action-reduce-prescription-drugObama executive order
5.
Centers for Disease Control and Prevention. Deaths associated with thiamine-deficient total parenteral nutrition. MMWR Morb Mortal Wkly Rep. 1989;38:43-46.
6.
KudskKAHolcombeBJBernsteinE. Shortage of intravenous multivitamin solution in the United States [letter]. N Engl J Med. 1997;337:54-55.
SacksGSRoughSKudskKA. Frequency and severity of harm of medication errors related to the parenteral nutrition process in a large university teaching hospital. Pharmacotherapy. 2009;29:966-974.
KochevarMGuenterPHolcombeBMaloneAMirtalloJ; A.S.P.E.N. Board of Directors and Task Force on Parenteral Nutrition Standardization. A.S.P.E.N. statement on parenteral nutrition standardization. JPEN J Parenter Enteral Nutr. 2007; 31:441-418.